Attachment 3a
MMP Medical Record Abstraction
Medical History Form
Medical Monitoring Project (MMP)
Medical Record Abstraction Form
2012 Medical History Form (MHF)
VERSION 7.1.0
 
O 
 PTIONAL-
FOR LOCAL USE ONLY
PTIONAL-
FOR LOCAL USE ONLY
| 
			 
 M Abstraction MMP Participant ID: Facility ID: (ID of the facility where abstraction is being conducted) 
 Medical record number: 
 
 
 Patient name: 
 
 Patient residence: 
 
 
 Street: 
   
 City/County: State: 
 
 
 
 
 
 
 
 ZIP code: 
 
 
 Physician name: | 
 
 
	DEPARTMENT OF HEALTH AND
	HUMAN SERVICES Centers
	for Disease Control & Prevention 
	
M 
 edical
Monitoring Project (MMP)
edical
Monitoring Project (MMP) 
Medical Record Abstraction Form
2012 Medical History Form (MHF) v7.1.0
| I. ABSTRACTION AND IDENTIFICATION | ||
| 
				 MMP Participant ID: | ||
| 
				 Surveillance Period (SP) 
 
				 SP start date: 
 
 (12 months prior to date of interview OR 1st contact attempt if no interview obtained) | 
				 
 SP end date: 
 
 (date of interview OR 1st contact attempt if no interview obtained) 
 | |
| 
				 Medical History Period (MHP) 
 
 MHP start date: (date of first HIV care (at any facility) documented in this medical record) 
 
 
 
 First visit to this facility: (date of first available visit to this facility for HIV care) 
 
 
 	 
 MHP end date: (day before the SP start date) 
 OR 
 
 HIV test result) 
 | ||
| 
				 
 Abstraction
				                                                                 
				        
				 Facility ID: 
 (ID of the facility where abstraction is being conducted) 
 | 
				 For the medical history period Abstract information on all HIV care documented in the medical records at the “Abstraction Facility” using a single MHF regardless of where the care was actually provided to the patient. | |
| 
				 
 Date of abstraction: Abstractor ID: 	 
					          Mo.
					                              Day                               
					             Year | ||
| II. PATIENT DEMOGRAPHICS | ||
| 
				 Date
				of birth:						 
					          Mo.
					                              Day                               
					      Year 
 
 
 
 If date of birth is not documented, enter documented age: 
 		
				 
				 
 
 
					          Mo.
					                                                Year | ||
| 
				 Most recent height (ft/in) prior to the SP start date: 
 
 	 		
								 
 
 
 
 
 
 
 
 
 
					    ft.
					               inches 
					 
 
 
 
 
 | ||
| 
				 Sex
				at birth:
				 	                         
				
				 (select
				one)
				                               
				
				
				
								 | ||
| 
				 Gender:
				                                    
				   
				 (select
				one)                                               
				 | ||
| II. PATIENT DEMOGRAPHICS cont’d | |||
| 
				 
 Hispanic
				or Latino ethnicity:
				  
				 (select
				one)
				                                
				   
				 
 
 | |||
| 
				 
 Race:
				                                        	1 (select
				all that are documented)             	2                    
				                               	
				3                    
				                             	4                    
				                             	
				5 
 
 
 
 
 	6 | |||
| 
				 
 Country
				of birth:	1 (select
				one)
				  	2 	 	3 
 	4 
 | |||
| III. MEDICAL HISTORY FORM SECTIONS - OPTIONAL | |||
| 
				 
 Is there documentation of any of the following prior to the SP start date? 
 
 
 | |||
| 
				 
 
 
      
				 | 
				 
 cell count, HIV viral load, or abnormal ALT (SGPT) or AST (SGOT)      
				 | ||
| 
				 
 (PCP) or Mycobacterium avium complex (MAC)      
				 | 
				 
 
      
				 | ||
| 
				 
 (TB)      
				 | 
				 
 substance abuse counseling or treatment      
				 | ||
| 
				 
 immunizations were given      
				 | 
				 
 depression      
				 | ||
| 
				 
      
				 | 
				 | ||
| IV. AIDS DEFINING OPPORTUNISTIC ILLNESSES (AIDS OI) | |||
| 
				 Is there documentation that any AIDS defining opportunistic illnesses (AIDS OI) were diagnosed prior to the SP start date? 
 
 | |||
| 
				 AIDS defining opportunistic illnesses (AIDS OI) prior to the SP start date (select all that are documented and record dates) 
 | 
 Date of first diagnosis 
 | Date not documented | |
| 
				 
   1 | 
				 | 
				 
 1 | |
| 
				 
   2 | 
				 | 
				 2 | |
| 
				 
   3 | 
				 | 
				 3 | |
| 
				   4 | 
				 | 
				 4 | |
| 
				 
   5 | 
				 | 
				 5 | |
| IV. AIDS DEFINING OPPORTUNISTIC ILLNESSES (AIDS OI) cont’d | |||
| AIDS defining opportunistic illnesses (AIDS OI) prior to the SP start date (select all that are documented and record dates) 
 | 
 Date of first diagnosis 
 | Date not documented | |
| 
				 
   6 | 
				 | 
				 6 | |
| 
				   7 | 
				 | 
				 7 | |
| 
				 
   8 | 
				 | 
				 8 | |
| 
				 
   9 | 
				 | 
				 9 | |
| 
				 10 bronchitis, pneumonitis, or esophagitis | 
				 | 
				 10 | |
| 
				 
 11 | 
				 | 
				 11 | |
| 
				 
 12 | 
				 | 
				 12 | |
| 
				 
 13 | 
				 | 
				 13 | |
| 
				 
 14 | 
				 | 
				 14 | |
| 
				 
 15 | 
				 | 
				 15 | |
| 
				 
 16 | 
				 | 
				 16 | |
| 
				 17 Extrapulmonary | 
				 | 
				 17 | |
| 
				 
 18 | 
				 | 
				 18 | |
| 
				 
 19 | 
				 | 
				 19 | |
| 
				 20 disseminated or extrapulmonary | 
				 | 
				 20 | |
| 
				 
 21 | 
				 | 
				 21 | |
| 
				 
 22 | 
				 | 
				 22 | |
| 
				 23 | 
				 | 
				 23 | |
| 
				 
 24 | 
				 | 
				 24 | |
| 
				 
 25 | 
				 | 
				 25 | |
| 
				 
 26 | 
				 | 
				 26 | |
| V. PROPHYLAXIS | |||
| 
				 Is there documentation of prescription for prophylaxis of Pneumocystis jiroveci pneumonia (PCP) prior to the SP start date?              
				 
 Prescription must be for PCP prophylaxis. Medications include: Bactrim® (Septra, Cotrim, Co-trimoxazole, trimethorprim, sulfamethoxazole) Dapsone® Pentamidine® (pentamidine isothianate) Mepron® or Mepron® Suspension (atovaquone) Clindamycin® (clindamycin hydrochloride) + Primaquine® (primaquine phosphate) Dapsone® + Daraprim® (pyrimethamine) + Folinic Acid 
 | 
				 Is there documentation of prescription for prophylaxis of Mycobacterium avium complex (MAC) prior to the SP start date?             
				 
 Prescription must be for MAC prophylaxis. Medications include: Biaxin Filmtab® (clarithromycin) Biaxin Granules® Biaxin XL® Zithromax® Zithromax Single Pack® (azithromycin, azithromycin dihydrate) Mycobutin® (rifabutin) 
 | ||
| VI. HEPATITIS, TOXOPLASMA, AND TUBERCULOSIS (TB) SCREENING | ||||
| Is there documentation of screening for hepatitis A, B, C, Toxoplasma, or tuberculosis (TB) prior to the SP start date? 
 
 | ||||
| 
				 
 Was hepatitis A screening performed prior to the SP start date? (select one) 
  1 
  2 
  3 | ||||
| 
				 If “Yes,” what were the results? 
 Select all that apply OR result not documented 
 | ||||
| 
				        
				 
 | 
				Date
				of 1st
				positive test:
				    
				 
 
 
 
 
 | 
				 Which Hepatitis A test(s) was/were positive on this date? (select all that apply) 
				 
 
 
 | ||
| 
				 
        
				 
 | 
				 
 Date of last negative test: 
 
 
 
 
 | 
				 | ||
| 
				        
				 | ||||
| 
				 Was hepatitis B screening performed prior to the SP start date? (select one) 
  1 
   
  3 | ||||
| 
				 If “Yes,” what were the results? 
 Select all that apply OR result not documented 
 | ||||
| 
				        
				 
 | 
				Date
				of 1st
				positive test:
				    
				 
 
 
 
 
 | 
				 Which Hepatitis B test(s) was/were positive on this date? (select all that apply) 
				 
				 
				 
				 
				 
				 
				                   
				                                                                 
				    
				 | ||
| 
				        
				 
 | 
				 Date of last negative test: 
 
 
 
 
 | 
				 | ||
| 
				        
				 | ||||
| 
				 
 Was hepatitis C screening performed prior to the SP start date? (select one) 
   1 
   
   3 | ||||
| 
				 If “Yes,” what were the results? 
 Select all that apply OR result not documented | ||||
| 
				        
				 
 | 
				Date
				of 1st
				positive test:
				    
				 
 
 
 
  
				 | 
				 Which Hepatitis C test(s) was/were positive on this date? (select all that apply) 
				 
 
				 
 
 | ||
| 
				        
				 
 | 
				 
 Date of last negative test: 
 
 
 
 
 | 
				 | ||
| 
				         
				 | ||||
| VI. HEPATITIS, TOXOPLASMA, AND TUBERCULOSIS (TB) SCREENING cont’d | ||||||||
| 
				 Was Toxoplasma screening performed prior to the SP start date? (select one) 
 1 
 2 
 3 
 Was there a positive result for the most recent Toxoplasma antibody titer prior to the SP start date? (select one) 
 
 
 
 
       1 
       2 
       3 | ||||||||
| 
				 Was screening for tuberculosis (TB) performed prior to the SP start date? (select one) 
 1 
 2 
 3 
 
 Date of the most recent tuberculin skin test (TST/PPD/Mantoux) or QuantiFERON test (QFT) prior to the SP start date: 
 
 
 
 
 
 
 
 
 
 					 
 
 
 
 Result of the most recent TST/PPD/Mantoux or QFT prior to the SP start date: (enter one for TST/PPD/Mantoux OR one for QFT) | ||||||||
| 
				 
 TST/PPD/Mantoux: (enter OR select one)   Result in millimeters:                    
				 1 
                    
				 2 
                    
				 3 
                    
				 4 
                      5 | 
				 OR 
 
 
 
 
 
 | 
				 
 QFT: (select one) 
 1 
 2 
 3 
 4 | ||||||
| VII. HEPATITIS AND PNEUMOCOCCAL IMMUNIZATIONS | ||||||||
| 
				 Is there documentation of whether or not hepatitis A, B, A and B, or pneumococcal immunizations were given prior to the SP start date? 
 
 | ||||||||
| 
				 Was hepatitis A vaccine (Havrix, Vaqta) given prior to the SP start date? (select one: Yes, No, or Not documented) | ||||||||
| 
				 
   1 | 
				 
				 
				 
				   | Date not documented | ||||||
| 
				   2 | 
				 
 _____ 
 | 
				 
 
 
 
 
 
 | ||||||
| 
				   | ||||||||
| 
				 | Reason vaccine not given: (select one) | 
				 
   | 
				 
 
 
 
 | |||||
| 
				 | 
				 
 
 | Prior vaccination | 
				 
 
 | Patient declined | ||||
| 
				 | 
				 
 | Previously infected | 
				 
 | Not documented | ||||
| 
				 | 
				 
 | Other, specify | 
				 _____ 
 | 
				 
 
 
 | ||||
| 
				 | 
				 
 
 
 
 | |||||||
| 
				 4 
 
 | 
				 | 
				 | ||||||
| VII. HEPATITIS AND PNEUMOCOCCAL IMMUNIZATIONS cont’d | 
			 | ||||||||
| 
			 
 Was hepatitis B vaccine (Energix B, Recombivax) given prior to the SP start date? (select one: Yes, No, or Not documented) | 
			 | ||||||||
| 
			 
 
 1 | 
			 
			 
			   | Date not documented | 
			 | ||||||
| 
			    2 | 
			 
 _____ 
 | 
			 
 
 
 
 
 | 
			 | ||||||
| 
			   | 
			 | ||||||||
| 
			 | 
			 Reason vaccine not given: (select one) | 
			 
 
   | 
			 
 
 
 
 
 | 
			 | |||||
| 
			 | 
			 
 
 | Prior vaccination | 
			 
 
 | Patient declined | 
			 | ||||
| 
			 | 
			 
 | Previously infected | 
			 
 | Not documented | 
			 | ||||
| 
			 | 
			 
 | Other, specify | 
			 _____ | 
			 
 
 | 
			 | ||||
| 
			 
 | 
			  
 | 
			 | |||||||
| 
			 
 
 _____ 
 | 
			 
 
 
 
 
 | 
			 | |||||||
| 
			   4 | 
			 | ||||||||
| 
			 | 
			 | 
			 | |||||||
| 
			 
 Was combination hepatitis A and B vaccine (Twinrix) given prior to the SP start date? (select one: Yes, No, or Not documented) | 
			 | 
			 | |||||||
| 
			 
 
 1 | 
			 
			 
			   | Date not documented | 
			 | ||||||
| 
			    2 | 
			 
 _____ 
 | 
			 
 
 
 
 | 
			 | ||||||
| 
			   | 
			 | ||||||||
| 
			 | Reason vaccine not given: (select one) | 
			 
 _____ 
 | 
			 
 
 
 | 
			 | |||||
| 
			 | 
			 
 
 | Prior vaccination | 
			 
 
 | Patient declined | 
			 | ||||
| 
			 | 
			 
 | Previously infected | 
			 
 | Not documented | 
			 | ||||
| 
			 | 
			 
 | Other, specify | 
			 _____ 
 | 
			 
 | 
			 | ||||
| 
			 | 
			   
 
 
 | 
			 | |||||||
| 
			 | 
			 | 
			 | |||||||
| _____ 
 | 
			 | 
			 | |||||||
| 
			 
    4 | 
			 | ||||||||
| 
			 | 
			 | 
			 | |||||||
| 
			 
 
 Was pneumococcal vaccine (Pneumovax 23, Pneu-Immune 23) given prior to the SP start date? (select one Yes, No, or Not documented) | 
			 | ||||||||
| 
			 
 
 1 | 
			 
			 
 | 
			  
				          Mo.
				                                          Year 
 | Date not documented | 
			 | |||||
| 
			 
 2 | 
			 | 
			   
			 | 
			 | ||||||
| 
			 | 
			 Reason vaccine not given: (select one) | 
			 | |||||||
| 
			 | 
			 
 
 | Prior vaccination | 
			 
 
 | Patient declined | 
			 | 
			 | 
			 | ||
| 
			 | 
			 | 
			 | 
			 
 | Not documented | 
			 | ||||
| 
			 | 
			 
 | Other, specify | 
			 | ||||||
| 
			 | 
			 
 
 
 | 
			 | |||||||
| 
			 
 
 3 | 
			 | 
			 | |||||||
| VIII. ANTIRETROVIRAL THERAPY (ART) | ||||
| 
				 
 
 Is there documentation of prescription of antiretroviral therapy (ART) prior to the SP start date? 
 
 | ||||
| 
				 
 Date
				of first prescribed antiretroviral medication:   
				 				 
 Prescribed antiretroviral medications prior to the SP start date: (select all that are documented) | ||||
| 
				 
 1 | 
				 
   9 | 
				 17 (LPV/RTV, Kaletra, Meltrex) | 
				 
 25 | |
| 
				 2 Agenerase) | 
				 
 10 | 
				 
 18 | 
				 26 Aptivus) | |
| 
				 
 3 | 
				 11 Fuzeon) | 
				 
 19 | 
				 
 27 | |
| 
				 4 | 
				 12 | 
				 
 20 | 
				 28 | |
| 
				 
 5 | 
				 13 formerly TMC125) | 
				 21 MK-0518) | 
				 
 29 | |
| 
				 6 Prezista) | 
				14 Lexiva) | 
				 
 22 | 
				 30 Retrovir) | |
| 
				 7 Rescriptor) | 
				 
 15 | 
				 23 Invirase, Fortovase) | 
				 | |
| 
				 8 | 
				 
 16 | 
				 24 | 
				 | |
| 
				 
				 31 Specify: | ||||
| 
				 
 3 Specify: | ||||
| 
				 
 3 Specify: | ||||
| 
				 
 3 Specify: | ||||
| IX. LABORATORY TEST RESULTS | ||||
| 
				 
 
 Is there documentation of the first positive HIV test result, or laboratory test results for CD4 cell count, or HIV viral load, prior to the SP start date? 
 
 | ||||
| 
				 Is there documentation of the first positive HIV test result? 
 
 
 
 
 
 | ||||
| 
				 
 
 | 
				 | |||
| 
				 Is there documentation of CD4 cell count test results prior to the SP start date? 
 
 | ||||
| 
				 
 
 
 | 
				   Date
				of lowest CD4 cell count:
				 						 
 | |||
| 
				 
 Is there documentation of HIV viral load (VL) test results prior to the SP start date? 
 
 
 
 
 | ||||
| 
				 
 
 
 
 | 
				 
				 
				       
				          
				 | |||
| X. HIV ART RESISTANCE TESTING | ||
| 
				 Is there documentation of HIV ART resistance testing prior to the SP start date? 
 
 | ||
| 
				 Was genotypic ART resistance testing performed prior to the SP start date? (Select one: Yes, No, or Testing not documented) | ||
| 
				 | Select all ART classes documented with resistance and/or possible resistance: | |
| 
				 1 
 | 
 
 | |
| 
				 2 
 | 
 
 | |
| 
				 3 
 | 
				 | |
| 
				 4 
 | 
				 | |
| 
				 5 
 | ||
| 
				 6 | ||
| 
				 7 
 | ||
| 
				 Was phenotypic ART resistance testing performed prior to the SP start date? (Select one: Yes, No, or Testing not documented) | ||
| 
				 | 
				 Select all ART classes documented with resistance and/or intermediate resistance: | |
| 
				 1 
 | 
 
 | |
| 
				 2 
 | 
 
 | |
| 
				 3 
 | 
				 | |
| 
				 4 
 | 
				 | |
| 
				 5 
 | ||
| 
				 6 | ||
| 
				 7 
 | ||
| 
				 
 Was virtual phenotypic ART resistance testing performed prior to the SP start date? (Select one: Yes, No, or Testing not documented) | ||
| 
				 | Select all ART classes documented with resistance and/or possible / intermediate resistance reported: | |
| 
				 1 
 | 
 
 | |
| 
				 2 
 | 
 
 | |
| 
				 3 
 | 
				 | |
| 
				 4 
 | 
				 | |
| 
				 5 
 | ||
| 
				 6 | ||
| 
				 
 7 | ||
| XI. SUBSTANCE ABUSE | ||
| 
				 Is there documentation of reported or suspected alcohol abuse or other non-prescribed use of substances, including counseling or treatment for alcohol and/or substance use/abuse prior to the SP? 
 
 | ||
| 
				 Alcohol Abuse | ||
| 
				      Is
				there documentation of alcohol abuse prior to the SP?            
				
				 | ||
| 
				 Other Non-prescribed Use of Substances | ||
| 
				      Is
				there evidence of any injection
				substance use (e.g., track marks) documented prior to the SP?    
				
				 
 | ||
| XI. SUBSTANCE ABUSE cont’d | |||||||||
| 
			 
 Non-prescribed use of substances documented prior to the SP: (select all that are documented and type of use) | |||||||||
| 
			 
 
 
 Substance | Type of Use (select all that apply OR select Not documented) | ||||||||
| Injection | Non-Injection | Not documented | |||||||
| 
			   1 | 
			 
 
 | 
			 
 
 | 
			 
 
 | ||||||
| 
			   2 | 
			 
 
 | 
			 
 
 | 
			 
 
 | ||||||
| 
			   3 | 
			 
 
 | 
			 
 
 | 
			 
 
 | ||||||
| 
			   4 | 
			 | 
			 | 
			 | ||||||
| 
			   5 | 
			 | 
			 | 
			 | ||||||
| 
			   6 | 
			 | 
			 | 
			 | ||||||
| 
			   7 | 
			 
 
 | 
			 
 
 | 
			 
 
 | ||||||
| 
			   8 | 
			 | 
			 | 
			 | ||||||
| 
			   9 | 
			 | 
			 | 
			 | ||||||
| 
			 10 | 
			 
 
 | 
			 
 
 | 
			 
 
 | ||||||
| 
			 
 11 | 
			 
 
 | 
			 
 
 | 
			 
 
 | ||||||
| 
			 12 | 
			 
 
 | 
			 
 
 | 
			 
 
 | ||||||
| 
			 13 | 
			 | 
			 | 
			 | ||||||
| 
			 14 | 
			 | 
			 | 
			 | ||||||
| 
			 15 | 
			 
 
 | 
			 
 
 | 
			 
 
 | ||||||
| 
			 16 | 
			 | 
			 | 
			 | ||||||
| 
			 17 | 
			 | 
			 | 
			 | ||||||
| 
			 1 Specify: | 
			 
 
 
 
 | 
			 
 
 
 
 | 
			 
 
 
 
 | ||||||
| 
			 1 Specify: | 
			 
 
 
 
 | 
			 
 
 
 
 | 
			 
 
 
 
 | ||||||
| 
			 2 Specify: | 
			 
 
 
 
 | 
			 
 
 
 
 | 
			 
 
 
 
 | ||||||
| 
			 
 21 | 
			 
 
 | 
			 
 
 | 
			 
 
 | ||||||
| XII. MENTAL HEALTH | |||||||||
| 
			 
 Is there documentation of any of the following mental illnesses prior to the SP start date?  
			  
			 | |||||||||
| 
			 
 1 | Anxiety disorder (General anxiety disorder, GAD) | 
			 
 3 | Depression (Major depression, depressive disorder) | ||||||
| 
			 
 2 | Bipolar disorder | 
			 
 4 | Psychosis | ||||||
O PTIONAL-
FOR LOCAL USE ONLY
PTIONAL-
FOR LOCAL USE ONLY
MMP MHF v7.1.0
 
 
Abstraction
MMP Participant ID: Facility ID:
(ID of the facility where abstraction is being conducted)
| XIII. REMARKS | 
| 
			 
 | 
| 
			 
 | 
| 
			 
 | 
| 
			 
 | 
| 
			 
 | 
| 
			 
 | 
| 
			 
 | 
| 
			 
 | 
| 
			 
 | 
| 
			 
 | 
| 
			 
 | 
| 
			 
 | 
| 
			 
 | 
| 
			 
 | 
| 
			 
 | 
| 
			 
 | 
| 
			 
 | 
| 
			 
 | 
| 
			 
 | 
| 
			 
 | 
| 
			 | 
| 
			 
 | 
| 
			 
 | 
	 
		Page
		
	
| File Type | application/msword | 
| File Title | Medical monitoring project (MMP) | 
| Author | Rita Morgan | 
| Last Modified By | Ptomey, Natasha (CDC/OID/NCHHSTP) (CTR) | 
| File Modified | 2012-07-26 | 
| File Created | 2012-07-26 |